Roy Exum: My Pimples And Andrea Sloan

Monday, September 30, 2013 - by Roy Exum
Roy Exum
Roy Exum

A real long time ago I was having a fit with acne. I was a lovelorn teenager, infatuated with pretty girls in a dizzy game where pimples can really become cumbersome. It seemed like nothing was working and, after I grew a pimple large enough for its own zip code, I finally found a genius doctor who quickly became my lifelong hero when he came up with a marvelous idea.

At the time there was a new “super drug”  that was languishing through years of “clinical trials” in the United States and nobody could get any, despite the fact the revolutionary medicine was already available in Germany. My hero called up a close friend who was a German doctor and – presto! – the first 250 pills came flying across the ocean.

I had to promise that I would not sue anybody if I grew an extra set of ears, developed female breasts, or my eyes turned yellow, but, honestly, I would have dyed my hair green to get the American-made medicine. After I took a course of what was then identified by only a strange laboratory number, my pimples and my acne were gone forever. I had Clark Gable looks and never looked back. That’s a true story (except the Gable part.)

Other fellow Americans had to wait for many months. I don’t believe that's right. Since this occurred in my formative years, I have cursed the federal Food and Drug Administration for much of my adult life because the “clinical trials” process we use is horribly dysfunctional and in critical need of an overhaul.

To illustrate my point, allow me to introduce a beautiful Texas lawyer, Andrea Sloan. Yes, she is quite pretty but “beautiful” because her career has been as the executive director of a Texas advocacy project that provides free legal services to low-income victims of domestic or sexual abuse.

Andrea is a victim herself, not just of stage 3c ovarian cancer but a horribly-tangled FDA system. Her doctors have exhausted every known method to save her life. Six years of surgery, radiation, and chemotherapy haven’t worked. She’s still very much a patient at the world-famous M.D. Anderson Medical Center and her oncologist believes an experimental drug called “BMN 673” might well save Andrea’s life.

M.D. Anderson has a good supply of BMN 673 on hand but with millions of dollars at stake, the manufacturer, BioMarin in California, has said no. “It would be unethical and reckless to provide end-stage refractory ovarian cancer patients outside clinical trial with BMN 673 at this early stage of development,” said spokesperson Debra Charlesworth.

“If we did,” Charlesworth explained to CNN, “we would be exposing the experimental drug to a large group without adequate testing. There have been previous circumstances where early access to large groups has resulted in adverse consequences that were worse than the course of the disease.”

I am certain no scientist can hardly wait for somebody to try to explain to me what “adverse consequences” could possibly be worse than what Andrea Sloan is facing without BMN 673. Andrea is pleading for the drug – let the petals of the flower fall where they may – and probably understands the risks as much as anyone involved. She knows what will happen if she fails to get BMN 673 better than anyone else, too.

Here is what she wrote in a statement to the drug company: “I recognize the importance of weighing the risk and the myriad of considerations they face as a company. However, this is a risk worth taking. I will thank them. My family will thank them. An amazing army of loyal supporters, to whom I owe a debt of gratitude, will thank them. In America we do not leave our wounded warriors on the battleground. BioMarin, please be the Calvary that saves me.”

Her M.D. Anderson doctors believe Andrea is a great candidate. Further, the FDA itself has just announced Ms. Sloan qualifies for a “compassionate care” waiver in the rules but the manufacturer, BioMarin, still says no. The word is BioMarin stands to make about $500 million on the drug and, even though they say they plan to give away 10 percent of the medicine to charity, they refuse to face the ethical dilemma.

As of Sunday afternoon Andrea had almost 170,000 supporters on her Change.org webpage and politician Newt Gingrich, co-host of CNN’s “Crossfire” program, is irate at “a corporation protecting its wallet at the expense on Andrea’s possibly dying. If you want to know why big companies often get bad names, it’s explaining that clerical support to fill out FDA paperwork is too difficult when you can save a life.”

Dr. Charles Levenback, Andrea’s doctor, is disappointed at BioMarin’s stance but, as a man who sees the fight against cancer every day, he told CNN reporters, “My own belief is that the drug companies, the manufacturers, the insurance companies, the providers like my hospital M.D. Anderson, the individual medical professionals, the investigators, the patients -- everybody wants the same things. Safe, effect, novel therapies for as many people as it's appropriate for. Even BioMarin, I believe. I don't think this is like 'Let the masses eat cake.' I think they're on the same mission. But the whole system is giving this dysfunctional result."

On Andrea Sloan’s Facebook page there is a picture that tells of “Three Simple Rules.” The text reads, “If you don’t go after what you want in life, you will never have it. If you don’t ask, the answer will always be No. If you don’t step forward, you’ll always be in the same place.”

Those three rules got rid of my pimples but all we can do is pray for Andrea Sloan. She needs it right now.

royexum@aol.com


Thomas Gage, Not Cage

Re:  Roy Exum: Why The British Attacked   Dear Roy,  I think you'll find it was Thomas Gage, not "Cage" - a fact I learned at Sunnyside School. Thomas Cage is a company that sells avian supplies.  Lonnie Hatmaker (click for more)

Some Get It Wrong On Christians, The Inquisition And The Crusades

Some in the media, along with our President, have recently been accusing those who led the Crusades of being the worst mass murderers in history.  Conservative estimates cite approximately 1.7 million who were killed in the Crusades over a period of 200 years.  That would be 6,000 deaths a year.  As for the Inquisition, a total of about 3,000 were judged and sentenced ... (click for more)

State Attorney General Says City Council Cannot Make Taxis Not Registered In Hamilton County Go Through Emissions Testing

The state attorney general's office has ruled that the City Council cannot require that taxis not registered in Hamilton County go through emissions testing. The city is dealing with the new Uber taxi service that has an out-of-town owner. Locally-owned cabs have to go through the annual emissions testing. The opinion says that local taxi owners cannot get around the emissions ... (click for more)

Chattanooga Area Bracing For Possibility Of Isolated Severe Storms, Tornadoes Not Ruled Out

The National Weather Service is feeling uncertain about today's weather pattern and has not ruled out the possibility of isolated, severe thunderstorms or an isolated tornado in our area. The greatest threat seems to be between 4 and 7 p.m. this evening. Below is the latest update: HAZARDOUS WEATHER OUTLOOK...UPDATED NATIONAL WEATHER SERVICE MORRISTOWN TN 1122 AM EDT ... (click for more)

Hannah Wood Leads Red Bank To Two Tournament Wins

Friday was a pretty good day for the Red Bank Lionettes softball team. Hosting a six-team tournament, the Lionettes won two games on the opening day, holding off Lookout Valley by a 6-4 final in the first one before winning by a more comfortable 11-3 margin over Sequatchie County in the second one. Hannah Wood was the sparkplug in both as she had three hits twice and was the ... (click for more)

McCallie Soccer Remains Unbeaten With Win Over Rival Baylor

Hosting McCallie on Friday night, the Baylor soccer team knew that the first 15 minutes of the match would be key to a shot at upsetting its undefeated and top-ranked rival. The Red Raiders lasted 11 before the Blue Tornado struck.   McCallie opened the Division II-AA East/Middle Region match with high pressure, which paid off when Will McGregor finished a cross ... (click for more)